Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JNCE | FGEN | ACRS | ||
| Company | Jounce Therapeutics Inc | Fibrogen Inc CS | Aclaris Therapts | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.9200 | 1.0600 | 1.3200 | ||
| High | 1.9300 | 1.2800 | 1.4000 | ||
| Low | 1.8800 | 1.0600 | 1.3100 | ||
| Last | 1.8800 | 1.2600 | 1.3300 | ||
| Change | -0.0500 | +0.2100 | +0.0100 | ||
| % Change | -2.59% | +20.00% | +0.76% | ||
| Volume | 11,600,600 | 4,271,700 | 529,700 | ||
| 20-Day Average Volume | 1,541,820 | 2,676,315 | 1,474,505 | ||
| Previous Close | 1.9300 | 1.0500 | 1.3200 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.9078 | 0.9732 | 1.2448 | ||
| 20-Day Raw Stochastic | 16.67% | 96.67% | 69.70% | ||
| 20-Day Relative Strength | 62.73% | 58.07% | 60.04% | ||
| Weighted Alpha | -65.90 | -62.87 | -33.45 | ||
| Today's Opinion | 24% Buy | 24% Sell | 8% Buy | ||
| Previous Opinion | 40% Buy | 64% Sell | 8% Buy | ||
| Last Month's Opinion | 24% Buy | 56% Sell | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.59% since 04/26/23 | +18.87% since 07/15/24 | -1.48% since 07/15/24 | ||
| Low | 1.8800 on 05/03/23 | 1.0000 on 07/19/24 | 1.2600 on 07/18/24 | ||
| High | 1.9500 on 04/28/23 | 1.2800 on 07/22/24 | 1.4300 on 07/17/24 | ||
| 1-Month | |||||
| %Chg | +1.62% since 04/03/23 | +11.50% since 06/21/24 | +15.65% since 06/21/24 | ||
| Low | 1.8400 on 04/04/23 | 0.6801 on 07/03/24 | 1.1000 on 07/01/24 | ||
| High | 1.9800 on 04/17/23 | 1.2800 on 07/22/24 | 1.4300 on 07/17/24 | ||
| 3-Month | |||||
| %Chg | +55.37% since 02/03/23 | +10.53% since 04/22/24 | +9.02% since 04/22/24 | ||
| Low | 0.8957 on 03/10/23 | 0.6801 on 07/03/24 | 0.9515 on 05/29/24 | ||
| High | 1.9800 on 04/17/23 | 1.7400 on 05/07/24 | 1.4300 on 07/17/24 | ||
| 6-Month | |||||
| %Chg | -10.48% since 11/03/22 | +43.43% since 01/22/24 | +5.56% since 01/22/24 | ||
| Low | 0.5773 on 12/13/22 | 0.6801 on 07/03/24 | 0.9515 on 05/29/24 | ||
| High | 2.1180 on 11/09/22 | 2.9300 on 02/12/24 | 1.5100 on 03/06/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 98,954 | 104,448 | 94,070 | ||
| Shares Outstanding, K | 52,635 | 99,474 | 71,265 | ||
| Annual Sales | 82,000,000 | 147,750,000 | 31,250,000 | ||
| Annual Net Income | -50,920,000 | -284,230,000 | -88,480,000 | ||
| Last Quarter Sales | 82,000,000 | 55,900,000 | 2,400,000 | ||
| Last Quarter Net Income | 50,960,000 | -32,930,000 | -16,940,000 | ||
| 60-Month Beta | 0.75 | 0.71 | 0.27 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.60 on 11/10/22 | -0.33 on 05/06/24 | -0.24 on 05/07/24 | ||
| Latest Earnings Date | 05/04/23 | 08/05/24 | 08/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||